Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 8
2004 8
2005 20
2006 12
2007 7
2008 14
2009 13
2010 12
2011 11
2012 15
2013 12
2014 16
2015 17
2016 18
2017 10
2018 18
2019 35
2020 40
2021 44
2022 47
2023 37

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of therapeutic monoclonal antibodies.
Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Keizer RJ, et al. Among authors: huitema ad. Clin Pharmacokinet. 2010 Aug;49(8):493-507. doi: 10.2165/11531280-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20608753 Review.
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology.
Bruin MAC, Sonke GS, Beijnen JH, Huitema ADR. Bruin MAC, et al. Among authors: huitema adr. Clin Pharmacokinet. 2022 Dec;61(12):1649-1675. doi: 10.1007/s40262-022-01167-6. Epub 2022 Oct 11. Clin Pharmacokinet. 2022. PMID: 36219340 Free PMC article. Review.
Therapeutic drug monitoring of oral targeted antineoplastic drugs.
Mueller-Schoell A, Groenland SL, Scherf-Clavel O, van Dyk M, Huisinga W, Michelet R, Jaehde U, Steeghs N, Huitema ADR, Kloft C. Mueller-Schoell A, et al. Among authors: huitema adr. Eur J Clin Pharmacol. 2021 Apr;77(4):441-464. doi: 10.1007/s00228-020-03014-8. Epub 2020 Nov 9. Eur J Clin Pharmacol. 2021. PMID: 33165648 Free PMC article. Review.
Predictive Value of Microdose Pharmacokinetics.
van Nuland M, Rosing H, Huitema ADR, Beijnen JH. van Nuland M, et al. Among authors: huitema adr. Clin Pharmacokinet. 2019 Oct;58(10):1221-1236. doi: 10.1007/s40262-019-00769-x. Clin Pharmacokinet. 2019. PMID: 31030372 Review.
Individualized Pazopanib Dosing-Response.
Verheijen RB, Huitema AD, Steeghs N. Verheijen RB, et al. Among authors: huitema ad. Clin Cancer Res. 2016 Dec 15;22(24):6299. doi: 10.1158/1078-0432.CCR-16-2297. Clin Cancer Res. 2016. PMID: 27980023 No abstract available.
Toxicity and efficacy of chronomodulated chemotherapy: a systematic review.
Printezi MI, Kilgallen AB, Bond MJG, Štibler U, Putker M, Teske AJ, Cramer MJ, Punt CJA, Sluijter JPG, Huitema ADR, May AM, van Laake LW. Printezi MI, et al. Among authors: huitema adr. Lancet Oncol. 2022 Mar;23(3):e129-e143. doi: 10.1016/S1470-2045(21)00639-2. Lancet Oncol. 2022. PMID: 35240088 Review.
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.
van der Kleij MBA, Guchelaar NAD, Mathijssen RHJ, Versluis J, Huitema ADR, Koolen SLW, Steeghs N. van der Kleij MBA, et al. Among authors: huitema adr. Clin Pharmacokinet. 2023 Oct;62(10):1333-1364. doi: 10.1007/s40262-023-01293-9. Epub 2023 Aug 16. Clin Pharmacokinet. 2023. PMID: 37584840 Free PMC article. Review.
Fixed Dosing of Monoclonal Antibodies in Oncology.
Hendrikx JJMA, Haanen JBAG, Voest EE, Schellens JHM, Huitema ADR, Beijnen JH. Hendrikx JJMA, et al. Among authors: huitema adr. Oncologist. 2017 Oct;22(10):1212-1221. doi: 10.1634/theoncologist.2017-0167. Epub 2017 Jul 28. Oncologist. 2017. PMID: 28754722 Free PMC article. Review.
359 results